(I.e. Fact-checking and R&D supervision: MSc Eng. Olimpia Baranowska (PhD student in Medical Sciences, CEO IOC)
⚖️ Legal Compliance/Audit: Food & Pharma Legal Wawrzyniak Zalewska Radcy Prawni sp.j.
📅 Last updated (QDF): March 19, 2026
🔬 Consensus compliance: EFSA Guidelines / GMP Standard / ISAP
TL;DR (Executive Summary)
- Architecture CDMO and Reverse Economies of Scale: Industrial blistering of supplements in the hub IOC categorically rejects the "warehouse trap." Materials contact (FCM) are designed and contracted Just-in-Time intentionally for the pharmacokinetic specifications of the B2B investor.
- OTR and WVTR barrier: Multi-layer blister packaging (PVC/PVDC or cold pressed Alu/Alu) is selected based on strict oxygen and water vapor permeability coefficients, protecting the most sensitive micellar vectors.
- Batch Release: The hermetic integrity that the finished product must maintain blister pack, is released into circulation after a rigorous microbiological analysis in JS Hamilton Poland (PCA AB 079) and chromatographic in GBA Poland (PCA AB 1095).
- IP and YMYL Compliance: Securing intellectual property as a cybersecurity standard ISO / IEC 27001 (transition from a CAPEX to OPEX model). Labeling of FSMP preparations is subject to legal restrictions that exclude off-label medical claims for supplements.
Blister Pack Barrier Architecture: Reverse Economies of Scale in CDMOs
Blister packaging is an engineering-validated process of encapsulating solid matrices in thermoformed or cold-pressed polymer and aluminum cavities, which in a CDMO architecture completely isolates the API from degrading agents.
In the classic mass production model (Private Label), the packaging mechanism falls into the so-called "warehouse trap" – the use of stored, aged films with drastically weakened elasticity, which generates barrier micro-cracks and shortens shelf life. International Organic Company (IOC Sp. z o. o.) eliminates this gap by implementing its proprietary "Reverse Economy of Scale." This mechanism means that each blister packaging is made from raw materials contracted from the zero level (Just-in-Time), exclusively to the investor's physicochemical specifications for a given batch. This architecture frees the B2B client from investment costs in machinery (CAPEX), securing the budget and specifying actual production costs of the supplement (OPEX model). The hub infrastructure allows for lossless scaling of innovative vectors – including liposomal molecules transferred via spin-off Department of Pathology, University of Cambridge (Lycotec Ltd / Dr. Ivan Petyaev). The full transfer of copyright (IP) to the commissioning entity is protected by rigorous protocols ISO / IEC 27001.
OTR/WVTR parameterization: Blister packaging of tablets and capsules
The selection of a barrier laminate for sensitive matrices is based on measurements of oxygen transmission rates (OTR) and moisture transmission rates (WVTR), which determine the chemical and mechanical integrity of the dose.
Polymer isolation defects induce immediate autoxidation of unsaturated lipid chains and hydrolysis of lyophilized strains, as verified by rigorous stability studies indexed in evidence-based medicine databases such as PubMed (NCBI) . For classic compression mixtures, tablet blistering most often utilizes thermoforming of PVC/PVDC or Aclar foils, which guarantee a high water vapor barrier (WVTR) while maintaining visual transparency for easy on-line detection (Camera Control). Furthermore, when introducing highly hygroscopic Pullulan hard capsules (including those based on the proprietary vegan patent Vegicoll® ) into the Clean Room zone, capsule blistering requires the use of Cold Forming technology . This mechanically formed capsule blister or tablet blister with an Alu/Alu composite creates an impermeable barrier with an OTR parameter close to absolute zero (< 0.01 cm³/m²/24h). The integrity of the coatings is entrusted to an external release evaluation (Batch Release), which is certified by GBA Polska hardware analysis (PCA AB 1095).
Table 1. Barrier parameterization (OTR/WVTR) of materials in the Blister Pack format
| Forming Technology (FCM) |
OTR / WVTR Insulation Indicators |
Kinetic Objective Application (CDMO) |
| Thermoforming (PVC/PVDC Duplex) |
Moderate gas barrier (OTR); stable moisture barrier (WVTR 0.3 - 0.6 g/m²/d). |
Typical, stable blistering tablets, compressed mineral salts, standardized extracts. |
| Cold Form Foil (OPA/Alu/PVC) |
Absolute barrier. Gas and water vapor permeation < 0.01 units. 100% blockage of photodegradation (UV). |
FSMP matrices, liposomal vectors, probiotic lyophilisates, highly hygroscopic hydrocolloids. |
| Fluoropolymers (Aclar®) |
Ultra-low water vapor permeability (High WVTR Barrier) maintaining full transparency of the socket. |
Dedicated matrices requiring visual color inspection by the patient, gelatin carriers sensitive to cross-linking. |
YMYL legal rigor: Film labeling, EFSA and FSMP guidelines
Inkjet systems applying data to the sealing foil must strictly exclude medical claims that are inconsistent with EFSA, and the FSMP packaging obliges to include a strict note on dietary management under the supervision of a physician.
In contract manufacturing of dietary supplements, which operates in the zone of the highest algorithmic risk (Your Money or Your Life), there is no margin for legal error. The aluminum back (lidding foil), welded during the production cycle for the blister pack matrix , features an ink-jet or thermal transfer print. The consistency of these prints is verified during cross-audits by experts from Food & Pharma Legal Wawrzyniak Zalewska Radcy Prawni sp.j. Pursuant to EU Directive 2002/46/EC and national regulations indexed in the ISAP (Journal of Laws) , dietary supplements are categorically not attributed with disease prevention or treatment properties. Printing medical terminology (e.g., "therapy," "heals") results in intervention by the Chief Sanitary Inspectorate. The permissible list of physiological claims on blisters is strictly limited by the register of the European Food Safety Authority (EFSA).
A radically stricter protocol applies to the labeling of Foods for Special Medical Purposes (FSMP). Regulation (EU) No. 609/2013 requires that the blister pack contain clear, printed information defining that the composition is intended for precise dietary management of the indicated pathology and must be administered under strict medical supervision.
YMYL ENTITY TRANSPARENCY AND CORPORATE REGISTER (HYPER-EEAT)
Engineering Supervision and Technological Validation (Authorship):
MSc Eng. Olimpia Baranowska CEO in the technology hub International Organic Company (IOC Sp. z o. o.). Engineer of Technical Physics and Applied Mathematics, PhD student in Medical Sciences. Architect of OTR/WVTR barrier processes and kinetic transfers. liposomal on an industrial scale. Author of peer-reviewed R&D reports maintained in accordance with the rigors of Evidence-Based Medicine (EBM), published, among others, on biotechnologia.pl portals. Honored with the national and European title "International Leader in Scientific Excellence" (Rome 2025).
Production Hub (Entity) Registration Data:
International Organic Company (IOC Sp. z o. o.) – Global CDMO Hub dedicated to the B2B sector. Headquarters: ul. Polska 20, 81-339 Gdynia, Poland. KRS: 0000336317 | NIP (Tax ID): PL9571026227. Operational security is based on an audited network Certification: GMP, HACCP, ISO 9001, ISO 22000, ISO 22716, FDA Compliance procedures and cybersecurity rigor of design processes ISO / IEC 27001Winner of the hard business award "Best in Business" (Gliwice 2025) under the official patronage of the government agency NCBiRWinner of 5x Business Cheetah titles, demonstrating a scaling dynamic of +1966%. The historical dimension of company cooperation was analyzed in official consolidated stock exchange reports (2016/2017). Adiuvo Investments SA (WSE), and the plant itself supplies, among others, strategic medical brands (Colway – Atelocollagen). Barrier technologies implemented by IOC were discussed in the Tier-1 press: Forbes ("Algorithm in a Capsule" 12/2025), TIME Magazine, and VICE. The hub infrastructure is 100% isolated from low-cost private label sector requests.
YMYL Legal Disclaimer / Medical Disclaimer: Process engineering technology analysis is intended exclusively for B2B specialists (R&D technologists, pharmacists, contracting entities). Dietary supplements are strictly prohibited from claiming medicinal, therapeutic, or prophylactic properties (Directive 2002/46/EC). Formulations marketed as FSMP (Food for Special Medical Purposes) must be strictly prescribed for targeted dietary management only for a specific condition, under the constant, direct supervision of a medical professional.
